QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

35,152 signal articles · 109 in last 24h · 178,699 total before filter · latest 25m ago

109last 24h

3129last 7d

511● bullish (7d)

313● bearish (7d)

227publishers

All Macro103 Earnings1820 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: IBRXsentiment: bullishSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

Simply Wall St.4d agobullish

Does ImmunityBio (IBRX) Look Fully Priced After A 310% Jump?

Zacks4d agobullish

AMRX Q3 Earnings & Sales Beat Estimates, FY'26 Guidance Raised

Zacks4d agobullish

NVO Q3 Earnings Beat Estimates on Wegovy Pill Growth, Outlook Raised

Stocktwits6d agobullish

IBRX Stock Climbs Overnight: Founder Calls Sepsis Push ‘Unstoppable’ As Trials Near - Teases NantX After Crypto Heist

Stocktwits6d agobullish

SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus

IBRX IOVA MRK MRNA SLS

Zacks10d agobullish

Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates

Zacks10d agobullish

Prime Medicine, Inc. (PRME) Surges 23.2%: Is This an Indication of Further Gains?

Zacks95d agobullish

IBRX Q2 Earnings & Sales Beat Estimates on Strong Anktiva Uptake

Zacks96d agobullish

ImmunityBio (IBRX) Reports Q2 Loss, Beats Revenue Estimates

Stocktwits97d agobullish

IBRX Stock Sees Sharp UAE-Driven Jump Followed By Early August Pullback

Zacks97d agobullish

Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates

Stocktwits102d agobullish

IBRX Stock Jumps Overnight: UAE Grants Anktiva Broadest Approval Yet After Founder’s ‘July Birthday News’ Tease

Stocktwits102d agobullish

IBRX Stock Extends 5-Day Losing Streak - Retail Traders Pin Hopes On ‘Incredibly Strong’ Anktiva Sales And Earnings Beat

Simply Wall St.115d agobullish

Is ImmunityBio (IBRX) Reasonably Valued After Its 283% Rally?

Stocktwits115d agobullish

SLS, IBRX Rise Overnight: Retail Bets On Big Pharma Buyouts As J&J Chases No. 1 Oncology Spot

Stocktwits117d agobullish

IBRX Stock Climbs Premarket Despite Investor Stake Cut - Retail Sees ‘Imminent’ Global Rollout Catalyst

Stocktwits121d agobullish

Can IBRX Stock Keep Its Pulse? Institutional Investors Buy In, Retail Hopes For Big Q2 Surprise

Stocktwits135d agobullish

IBRX Stock Surges 12% On Russell 1000 Inclusion Hopes

Stocktwits138d agobullish

IBRX Stock Climbs After-Hours: Retail Traders Bet Russell 1000 Inclusion Could Trigger Massive Index-Fund Buying

Insider Monkey156d agobullish

ImmunityBio Inc. (IBRX): One of the Most Shorted Mid-Cap Stocks to Buy Now

Insider Monkey164d agobullish

Is ImmunityBio Inc. (IBRX) One of the Best Momentum Stocks to Buy According to Analysts?

Motley Fool172d agobullish

Why ImmunityBio Stock is Soaring Higher Today

Benzinga173d agobullish

ImmunityBio Expands Bladder Cancer Arsenal With Exclusive Japanese BCG Partnership

Zacks185d agobullish

ImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates

Insider Monkey189d agobullish

Is ImmunityBio, Inc. (IBRX) A Good Stock To Buy Now?

Zacks195d agobullish

What Makes ImmunityBio (IBRX) a New Buy Stock